You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

~ Buy the AMMONIUM GLYCYRRHIZATE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) AMMONIUM GLYCYRRHIZATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing AMMONIUM GLYCYRRHIZATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing AMMONIUM GLYCYRRHIZATE excipient

AMMONIUM GLYCYRRHIZATE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Ammonium Glycyrrhizinate

Introduction to Ammonium Glycyrrhizinate

Ammonium glycyrrhizinate, also known as mono-ammonium glycyrrhizinate, is a pharmaceutical excipient derived from glycyrrhizic acid, a compound found in licorice root. It is widely used for its anti-inflammatory, antiallergic, and antigastriculcer properties, making it a valuable component in various pharmaceutical, cosmetic, and food products[2].

Market Size and Growth

The global market for ammonium glycyrrhizinate has been experiencing significant growth. As of 2023, the market size was valued at several million dollars, with a projected compound annual growth rate (CAGR) that indicates substantial expansion from 2024 to 2031[1].

Historical and Forecasted Data

  • Historical Period: The market data from 2019 to 2023 provides a baseline for understanding the growth trajectory.
  • Forecast Period: From 2024 to 2031, the market is expected to grow at a notable CAGR, driven by increasing demand in various sectors[1].

Market Segmentation

The ammonium glycyrrhizinate market is segmented based on type and application.

By Type

  • High Purity: This segment is expected to dominate due to the high demand for high-quality excipients in pharmaceutical formulations.
  • Low Purity: Although less dominant, this segment still holds a significant share, particularly in non-pharmaceutical applications[4].

By Application

  • Pharmaceuticals: This is the most lucrative segment, driven by the need for effective and patient-friendly drug formulations. Ammonium glycyrrhizinate enhances the solubility, bioavailability, and stability of active pharmaceutical ingredients (APIs)[3][4].
  • Cosmetics and Personal Care: Used in perfumes, fragrances, and other cosmetic products for its skin-soothing properties[5].
  • Food Industry: Incorporated into various food products for its flavor and preservative qualities.
  • Others: Includes other niche applications where the compound's unique properties are beneficial[4].

Key Drivers

Several factors are driving the demand for ammonium glycyrrhizinate:

Increasing Chronic Diseases

The rise in chronic diseases such as diabetes, hypertension, cancer, and HIV necessitates the development of more effective drug formulations, which in turn increases the demand for innovative excipients like ammonium glycyrrhizinate[3].

Technological Advancements

Advancements in production technologies are enabling the manufacture of high-quality chemicals, which is a critical factor in the pharmaceutical industry. Companies are focusing on technological improvements to meet the growing demand for high-quality excipients[1].

Regulatory Compliance

Compliance with regulatory standards, such as those set by the European Chemicals Agency (ECHA), ensures that the production and use of ammonium glycyrrhizinate are safe and environmentally friendly. This compliance is a driving force behind the market's growth[5].

Key Players

The market is dominated by several key players who are driving innovation and expansion:

  • Tiansheng Pharmaceutical
  • Alps Pharmaceutical
  • Xinjiang Kunlunshengnong
  • Maruzen Pharmaceuticals
  • Longtong Pharma
  • Mafco
  • Fanzhi Pharmaceutical
  • Tianshan Pharmaceuticals

These companies are focusing on strategy building, product portfolio expansion, and business growth in the global market[4].

Regional Analysis

The market is analyzed across various regions, including North America, Europe, Asia Pacific, South America, and the Middle East and Africa. Each region has its own growth dynamics, with Asia Pacific expected to be a significant contributor due to its large consumer base and growing pharmaceutical industry[1].

Market Trends

Pharmaceutical Excipients Market Growth

The overall pharmaceutical excipients market, valued at $9.2 billion in 2023, is expected to grow to $12.4 billion by 2029 at a CAGR of 5.1%. This growth trend is indicative of the increasing demand for excipients like ammonium glycyrrhizinate[3].

Sustainability and ESG Factors

There is a growing emphasis on sustainability and environmental, social, and governance (ESG) factors in the chemical and materials industry. Companies are focusing on producing high-quality, environmentally friendly products, which is a positive trend for the ammonium glycyrrhizinate market[1].

Challenges and Restraints

Despite the growth, the market faces several challenges:

Raw Material Availability

The availability and cost of raw materials can fluctuate, affecting the production costs and profitability of ammonium glycyrrhizinate manufacturers.

Regulatory Hurdles

Stringent regulatory requirements can sometimes act as a barrier to entry for new players and may impose additional costs on existing manufacturers.

Competition

The market is competitive, with several players vying for market share. This competition can lead to pricing pressures and the need for continuous innovation to stay competitive[1].

Financial Trajectory

The financial trajectory of the ammonium glycyrrhizinate market is positive, with significant growth projected over the next several years.

  • Revenue Forecast: The market is expected to grow from its current value to several billion dollars by 2031, driven by the increasing demand in pharmaceutical and other sectors[1].
  • Investment Opportunities: The growing demand and positive market outlook present attractive investment opportunities for companies looking to expand their presence in the excipients market[4].

Key Takeaways

  • Growing Demand: The market is driven by increasing demand in pharmaceuticals, cosmetics, and the food industry.
  • Technological Advancements: Improvements in production technologies are crucial for meeting the demand for high-quality excipients.
  • Regulatory Compliance: Adherence to regulatory standards is essential for market growth.
  • Competitive Landscape: The market is dominated by several key players who are driving innovation and expansion.
  • Financial Growth: The market is expected to experience significant financial growth over the forecast period.

FAQs

What are the primary applications of ammonium glycyrrhizinate?

The primary applications include pharmaceuticals, cosmetics and personal care, and the food industry.

Who are the key players in the ammonium glycyrrhizinate market?

Key players include Tiansheng Pharmaceutical, Alps Pharmaceutical, Xinjiang Kunlunshengnong, Maruzen Pharmaceuticals, Longtong Pharma, Mafco, Fanzhi Pharmaceutical, and Tianshan Pharmaceuticals.

What is the expected CAGR of the ammonium glycyrrhizinate market from 2024 to 2031?

The exact CAGR is not specified in the sources, but it is indicated to be significant and positive.

How does the rise in chronic diseases impact the demand for ammonium glycyrrhizinate?

The rise in chronic diseases necessitates the development of more effective and patient-friendly drug formulations, which increases the demand for innovative excipients like ammonium glycyrrhizinate.

What are the main types of ammonium glycyrrhizinate?

The main types are high purity and low purity, with high purity being the more dominant segment.

Sources

  1. Cognitive Market Research: "Global Mono-Ammonium Glycyrrhizinate Market Report 2024 (Global Edition)"
  2. MedChemExpress: "Monoammonium glycyrrhizinate; Glycyrrhizic acid ammonium salt"
  3. BCC Research: "Understanding the Future of Pharmaceutical Excipients"
  4. Valuates Reports: "Mono-Ammonium Glycyrrhizinate Market, Report Size, Worth ..."
  5. ECHA: "Ammonium glycyrrhizate - Substance Information - ECHA"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.